首页|温肾培元降毒汤联合复方α-酮酸片对慢性肾衰竭患者的肾保护效果观察及机制初探

温肾培元降毒汤联合复方α-酮酸片对慢性肾衰竭患者的肾保护效果观察及机制初探

Protective Effect and Mechanism of Wenshen Peiyuan Jiangdu Decoction Combined with Compoundα-ketoacid Tablets on Patients with Chronic Renal Failure

扫码查看
目的:观察温肾培元降毒汤联合复方α-酮酸片治疗慢性肾衰竭的临床效果,初步探讨其肾保护效果及机制.方法:将112 例慢性肾衰竭患者按照随机数字表法分为对照组(n=56)和观察组(n=56).对照组患者给予复方α-酮酸片治疗,观察组在对照组基础上给予温肾培元降毒汤口服,连续治疗4 周.比较两组总有效率、中医证候总积分、肾功能指标[血肌酐(Scr)、肾小球滤过率(eGFR)、尿素氮(BUN)]、肾纤维化指标[结缔组织生长因子(CTGF)、金属蛋白酶组织抑制因子-1(TIMP-1)、Ⅳ型胶原(CⅣ)]、血清钙磷、氧化应激指标[过氧化脂质(LPO)、丙二醛(MDA)、超氧化物歧化酶(SOD)]水平.结果:观察组、对照组的有效率分别为 91.07%、76.79%,以观察组疗效更好(P<0.05);随着治疗疗程的增多,两组患者的中医证候总积分均明显降低,低于治疗前(P<0.05);同一时间点与对照组进行组间比较,观察组的中医证候总积分均明显降低(P<0.05);治疗2 个疗程后,观察组患者的Scr、BUN含量明显低于对照组,eGFR明显高于对照组,肾纤维化指标CTGF、TIMP-1、CⅣ水平明显低于对照组,血钙含量明显高于对照组,血磷含量明显低于对照组,血清中LPO、MAD含量均明显低于对照组,SOD含量明显高于对照组(P<0.05).结论:温肾培元降毒汤联合复方α-酮酸片治疗慢性肾衰竭疗效确切,可能通过减轻肾纤维化、抗氧化应激等发挥肾保护作用,从而利于减轻症状,调节钙磷代谢,促进肾功能的恢复.
Objective:To observe the clinical effect of Wenshen Peiyuan Jiangdu Decoction combined with compound α-ketoacid tablets in the treatment of chronic renal failure,and preliminarily explore the protective effect and mechanism of kidney.Methods:112 patients with chronic renal failure were divided into control group(n=56)and observation group(n=56)according to random number table method.Control group was treated with compound alpha-ketoic acid tablets,and observation group was addi-tionally treated with Wenshen Peiyuan Jiangdu Decoction orally for 4 weeks.The total effective rate,total scores of TCM syndromes,renal function indexes[blood creatinine(Scr),glomerular filtration rate(eGFR),urea nitrogen(BUN)],renal fibrosis indexes[connective tissue growth factor(CTGF),tissue inhibitor of metalloproteinase-1(TIMP-1),collagen type Ⅳ(CⅣ)]and the serum calcium and phosphorus,oxidative stress index[lipid peroxide(LPO),malondialdehyde(MDA),superoxide dismutase(SOD)]were compared between the two groups.Results:The effective rate of the observation group and the control group were 91.07%and 76.79%respectively,and the observation group had better curative effect(P<0.05).With the increase of treatment course,the total scores of TCM syndrome in 2 groups were significantly decreased,lower than before treatment(P<0.05);Com-pared with the control group at the same time point,the total scores of TCM syndromes in the observation group were significantly de-creased(P<0.05).After2 courses of treatment,the observation group of patients with Scr,BUN content is significantly lower than the control group,eGFR is significantly higher than the control group,renal fibrosis index CTGF,TIMP-1,CⅣ level is significantly lower than the control group,blood calcium content is significantly higher than the control group,blood phosphorus content is signifi-cantly lower than the control group,serum LPO,MAD content are significantly lower than the control group.The SOD content was significantly higher than that in control group(P<0.05).Conclusion:Wenshen Peiyuan Jiangdu Decoction combined with compound α-ketoacid tablets has definite curative effect in the treatment of chronic renal failure,which may play a renal protective role by alle-viating renal fibrosis and anti-oxidative stress,so as to help alleviate symptoms,regulate calcium and phosphorus metabolism,and promote the recovery of renal function.

Warming kidney Peiyuan Jiangdu decoctionCompound α-ketoacid tabletsChronic renal failureRenal protection

张雨帆、姜敏敏

展开 >

上海市杨浦区控江医院中西医结合科(上海 200093)

温肾培元降毒汤 复方α-酮酸片 慢性肾衰竭 肾保护

上海市卫健委课题

202040026

2024

中国中西医结合肾病杂志
中国中西医结合学会

中国中西医结合肾病杂志

CSTPCD
影响因子:1.061
ISSN:1009-587X
年,卷(期):2024.25(7)